Parkinson’s disease: multiple ascending dose
Related insights
More from our insights
Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support
Download ArticleSharing our best patient-centric practices from extensive experience in Alzheimer’s Disease.
At Fortrea, we’re committed to advancing research in Alzheimer’s Disease (AD) and other dementias. Learn about our best practices and recommendations developed from years of experience advancing these complex studies.
Download ArticleApplying a patient- and site-centric approach in an early Phase I Alzheimer’s disease study
This case study discusses how Fortrea applied creative problem-solving to work though inherent challenges and shares a unique enrollment strategy for supporting sites and patients.
Download Case StudyEnhancing endpoint protection in pain management clinical trials
Key considerations for endpoint protection in pain management clinical trials
Read morePromoting patient and site centricity in neurodegenerative disease clinical trials
Download White PaperOperationalizing complex, rare neuromuscular clinical trials
Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support.
Download ArticlePatient-centric practices for AD
Sharing our best patient-centric practices from extensive experience in Alzheimer’s Disease.
Download ArticlePhase I Alzheimer’s Disease
Applying a patient- and site-centric approach in an early Phase I Alzheimer’s Disease study
Download Case StudyImportance of patient perspectives in neurology clinical trials
Incorporating patient perspectives through interviews in neurology clinical trials
Connect with us
We’ve been driving innovation with our tailored clinical solutions for 30+ years. Let’s connect.